These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 30809278)

  • 1. Low Molecular Weight Heparin-Coated and Dendrimer-Based Core-Shell Nanoplatform with Enhanced Immune Activation and Multiple Anti-Metastatic Effects for Melanoma Treatment.
    Xia C; Yin S; Xu S; Ran G; Deng M; Mei L; Tang X; Rao J; Li M; Zhang Z; He Q
    Theranostics; 2019; 9(2):337-354. PubMed ID: 30809278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A low-molecular-weight heparin-coated doxorubicin-liposome for the prevention of melanoma metastasis.
    Chen Y; Peng J; Han M; Omar M; Hu D; Ke X; Lu N
    J Drug Target; 2015 May; 23(4):335-46. PubMed ID: 25541466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polydopamine-based nanoplatform for photothermal ablation with long-term immune activation against melanoma and its recurrence.
    Li M; Guo R; Wei J; Deng M; Li J; Tao Y; Li M; He Q
    Acta Biomater; 2021 Dec; 136():546-557. PubMed ID: 34536603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-delivery of doxorubicin and epacadostat via heparin coated pH-sensitive liposomes to suppress the lung metastasis of melanoma.
    Chen Y; Du Q; Zou Y; Guo Q; Huang J; Tao L; Shen X; Peng J
    Int J Pharm; 2020 Jun; 584():119446. PubMed ID: 32439586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced graphene oxide nanosheets coated with an anti-angiogenic anticancer low-molecular-weight heparin derivative for delivery of anticancer drugs.
    Shim G; Kim JY; Han J; Chung SW; Lee S; Byun Y; Oh YK
    J Control Release; 2014 Sep; 189():80-9. PubMed ID: 24973719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low molecular weight heparin modified bone targeting liposomes for orthotopic osteosarcoma and breast cancer bone metastatic tumors.
    Wu H; Luo Y; Xu D; Ke X; Ci T
    Int J Biol Macromol; 2020 Dec; 164():2583-2597. PubMed ID: 32795579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low molecular weight heparin-based reduction-sensitive nanoparticles for antitumor and anti-metastasis of orthotopic breast cancer.
    Sun H; Cao D; Liu Y; Wang H; Ke X; Ci T
    Biomater Sci; 2018 Jul; 6(8):2172-2188. PubMed ID: 29942949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ZnO-based multifunctional nanocomposites to inhibit progression and metastasis of melanoma by eliciting antitumor immunity via immunogenic cell death.
    Zhang Y; Guo C; Liu L; Xu J; Jiang H; Li D; Lan J; Li J; Yang J; Tu Q; Sun X; Alamgir M; Chen X; Shen G; Zhu J; Tao J
    Theranostics; 2020; 10(24):11197-11214. PubMed ID: 33042278
    [No Abstract]   [Full Text] [Related]  

  • 9. Antitumor and Antimetastasis Activities of Heparin-based Micelle Served As Both Carrier and Drug.
    Mei L; Liu Y; Zhang H; Zhang Z; Gao H; He Q
    ACS Appl Mater Interfaces; 2016 Apr; 8(15):9577-89. PubMed ID: 27058058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymer-Drug Nanoparticles Combine Doxorubicin Carrier and Heparin Bioactivity Functionalities for Primary and Metastatic Cancer Treatment.
    Mei L; Liu Y; Xia C; Zhou Y; Zhang Z; He Q
    Mol Pharm; 2017 Feb; 14(2):513-522. PubMed ID: 28026951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy priming of the Pancreatic Tumor Microenvironment Promotes Delivery and Anti-Metastasis Efficacy of Intravenous Low-Molecular-Weight Heparin-Coated Lipid-siRNA Complex.
    Yu Q; Qiu Y; Chen X; Wang X; Mei L; Wu H; Liu K; Liu Y; Li M; Zhang Z; He Q
    Theranostics; 2019; 9(2):355-368. PubMed ID: 30809279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of pegylated dendrimeric nanocarrier for pulmonary delivery of low molecular weight heparin.
    Bai S; Ahsan F
    Pharm Res; 2009 Mar; 26(3):539-48. PubMed ID: 19034631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of low molecular weight heparin based nanoparticles for metastatic breast cancer therapy.
    Sun H; Cao D; Wu H; Liu H; Ke X; Ci T
    Int J Biol Macromol; 2018 Jun; 112():343-355. PubMed ID: 29409771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CpG-1826 immunotherapy potentiates chemotherapeutic and anti-tumor immune responses to metronomic cyclophosphamide in a preclinical glioma model.
    Jordan M; Waxman DJ
    Cancer Lett; 2016 Apr; 373(1):88-96. PubMed ID: 26655275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. G3139 and other CpG-containing immunostimulatory phosphorothioate oligodeoxynucleotides are potent suppressors of the growth of human tumor xenografts in nude mice.
    Gekeler V; Gimmnich P; Hofmann HP; Grebe C; Römmele M; Leja A; Baudler M; Benimetskaya L; Gonser B; Pieles U; Maier T; Wagner T; Sanders K; Beck JF; Hanauer G; Stein CA
    Oligonucleotides; 2006; 16(1):83-93. PubMed ID: 16584297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low systemic toxicity nanocarriers fabricated from heparin-mPEG and PAMAM dendrimers for controlled drug release.
    Thanh VM; Nguyen TH; Tran TV; Ngoc UP; Ho MN; Nguyen TT; Chau YNT; Le VT; Tran NQ; Nguyen CK; Nguyen DH
    Mater Sci Eng C Mater Biol Appl; 2018 Jan; 82():291-298. PubMed ID: 29025661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-delivery of Doxorubicin and Interferon-γ by Thermosensitive Nanoparticles for Cancer Immunochemotherapy.
    Yin Y; Hu Q; Xu C; Qiao Q; Qin X; Song Q; Peng Y; Zhao Y; Zhang Z
    Mol Pharm; 2018 Sep; 15(9):4161-4172. PubMed ID: 30011369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination chemotherapy of doxorubicin, all-trans retinoic acid and low molecular weight heparin based on self-assembled multi-functional polymeric nanoparticles.
    Zhang T; Xiong H; Dahmani FZ; Sun L; Li Y; Yao L; Zhou J; Yao J
    Nanotechnology; 2015 Apr; 26(14):145101. PubMed ID: 25771790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune lipoprotein nanostructures inspired relay drug delivery for amplifying antitumor efficiency.
    Han Y; Ding B; Zhao Z; Zhang H; Sun B; Zhao Y; Jiang L; Zhou J; Ding Y
    Biomaterials; 2018 Dec; 185():205-218. PubMed ID: 30245388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A targeted nanoplatform co-delivering chemotherapeutic and antiangiogenic drugs as a tool to reverse multidrug resistance in breast cancer.
    Tian F; Dahmani FZ; Qiao J; Ni J; Xiong H; Liu T; Zhou J; Yao J
    Acta Biomater; 2018 Jul; 75():398-412. PubMed ID: 29874597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.